Company profile
NanoSphere Health Sciences Inc.
OTC: NSHSF · Healthcare · Biotechnology
Canadian filerHQ Vancouver, BCReports USD
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH 9DQ —GM —SS 34
v0.1 · 35/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ Altman-Z, balance-sheet leverage
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$86.3k
Employees
3
as of 2026-08-28
Market cap
$102.8k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02025
Net income-$86.3k-$86.3k2025
Operating income-$181.9k-$181.9k2025
Total assets$16.8k$16.8k2025
Liabilities$1.4M$1.4M2025
Equity-$1.3M-$1.3M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is NanoSphere Health Sciences Inc.’s revenue?
NanoSphere Health Sciences Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Manzo Pharmaceuticals, Inc.57CImmunotech Laboratories, Inc.——Link Reservations Inc.——Many Bright Ideas Technologies Inc.——Priority Aviation, Inc.——Drug Free Solution, Inc.——Key facts
CEOMichael Alexander Iverson
SectorHealthcare
IndustryBiotechnology
HeadquartersVancouver, BC
ExchangeOTC: NSHSF
Employees3
IPO date2009-10-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.